Cor Vasa 2009, 51(11-12):834

Nahradí nová antiagregancia clopidogrel?

MUDr. Pavel Jerie
Leymenstrasse 49, CH 4153 Reinach, BL 1, ©výcarsko

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jerie P. Nahradí nová antiagregancia clopidogrel? Cor Vasa. 2009;51(11-12):834.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bhatt DL. Prasugrel in clinical practice. N Engl J Med 2009;361:940-2. Go to original source... Go to PubMed...
    2. Unger EF. Weighing benefits and risks-The FDA's Rewiew of Prasugrel. N Engl J Med 2009;361:942-5. Go to original source... Go to PubMed...
    3. Walentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57. Go to original source... Go to PubMed...
    4. Schömig A. Ticagrelor - is there need for a new player in the atiplatelet-therapy field? N Engl J Med 2009;361:1108-11. Go to original source... Go to PubMed...

    Return to the content